REDUCE
Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients - a prospective cohort study
Sponsors:
Amsterdam University Medical Center
Amsterdam, the Netherlands
Design
Multinational, prospective, observational cohort study to evaluate clinical outcomes during guideline-recommended LMWH dose escalation for recurrent VTE during LMWH or DOAC treatment for recurrent cancer-associated thrombosis
Participating Sites

Lead Network:
DTNCountries:
Italy, The Netherlands,Lead Investigators
Dr. Floris T.M. Bosch, MD
Amsterdam University Medical Center
Amsterdam, the Netherlands
Dr. Marcello Di Nisio, MD, PhD
Gabriele D'Annunzio University
Chieti, Italy
Subscribe